QIAGEN N.V. (QGEN)
- Headquarters
- United States
- Employees
- 5,500
- Market Cap
- $8.7B
About QIAGEN N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
SentiSense also tracks daily options readings for QIAGEN N.V.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
QIAGEN N.V. stock analysis, sentiment tracking, and market intelligence on SentiSense.